Filgotinib may be associated with a lower risk of herpes zoster compared with other Janus kinase inhibitors in rheumatoid arthritis.

IGNYTE showed that patients with confirmed progression on an anti-PD-1-based regimen who received RP1 plus nivolumab had a 34% response rate, with a median duration of 24.8 months, and 15% of them ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from two Phase 3 trials evaluating the efficacy and safety of LITFULO once daily in patients with both active and stable nonsegmental ...

HSV-1 – WHO’s report breaks down herpes symptoms, prevention, treatment, and why stigma is the real problem. | Health ...

A webcast of the presentation will be available by selecting Events and Presentations in the Investors section of Candel’s website at www.candeltx.com. A replay of the webcast will be archived for up ...

Herpetic infection signals differ across targeted therapies for patients with AD, including for overall and type-specific herpetic infections.

HSV type 1 reactivation was prevalent among critically ill patients with COVID-19 and was independently associated with ...

Research has shown that the use of JAK inhibitors can weaken rheumatoid arthritis patients' responses to shingles vaccination ...

Among patients with AD, difamilast is associated with a comparable skin infection incidence rate to that of TCS and non-TCS therapies.

Recombinant zoster vaccine is highly effective and safe for patients with inflammatory rheumatic diseases receiving immunosuppressive therapies.

Data presented at the campaign show that individuals with high blood pressure, high cholesterol, or coronary heart disease ...

People who arrive at one of Multnomah County’s community health clinics to get tested for herpes or have their teeth cleaned have little idea that the clinics they visit are enmeshed in a web of ...